Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.33 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 0.22 | N/A |
P/B Ratio (TTM) | 0.24 | N/A |
P/FCF Ratio (TTM) | -1.54 | N/A |
Price to 5YR AVG Earnings Ratio | -2.43 | N/A |
Price to 5YR AVG FCF Ratio | -4.51 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -8.99% | N/A |
ROE (TTM) | -15.79% | N/A |
Net Profit Margin (TTM) | -15.98% | N/A |
ROIC 5YR AVG | -0.97% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -2,527.60% | -379.40% | -300.92% |
Revenue | -3.90% | -10.10% | -3.78% |
Net Income | -827.24% | -387.89% | -283.35% |
Cash Flow | -121.00% | -31.52% | -355.61% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.83 | N/A |
Quick Ratio (TTM) | 1.33 | N/A |
D/E Ratio (TTM) | 0.36 | N/A |
Interest Coverage (TTM) | -0.13 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 0.83 | N/A |
LTL to 5YR AVG FCF | -7.76 | N/A |
Shares Outstanding Growth 5YR AVG | 3.61% | N/A |